Citation Impact
Citing Papers
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
2009
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Pancreatic cancer
2004 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Improving Survival and Reducing Toxicity with Chemotherapy in Advanced Non-Small Cell Lung Cancer
2005
Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex
2003
Generalist plus Specialist Palliative Care — Creating a More Sustainable Model
2013 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment
1995
Lung cancer: New biological insights and recent therapeutic advances
2011
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis
2004 StandoutNobel
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life
2004
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Liver-Derived Hepatitis C Virus (HCV)-Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma
2000 StandoutNobel
Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience
1997
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
2005
Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial
1995
Palliative Care
2009
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033
2002
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer
1993
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
2000
Mycobacterium xenopi Pneumonia in the Southeastern United States
2003
Tuberculosis Serodiagnosis in a Predominantly HIV-Infected Population of Hospitalized Patients with Cough, Botswana, 2002
2004
Microtubules as a target for anticancer drugs
2004 Standout
Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease
1999
Induction of CD8 T-cell-Ifn-γ response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma
2003
A model for decision making for the use of radiotherapy in lung cancer
2003
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
The link between the nose and lung, perennial rhinitis and asthma—is it the same disease?
1997
‘Unqualified Success’ and ‘Unmitigated Failure’ Number-Needed-to-Treat-Related Concepts for Assessing Treatment Efficacy in the Presence of Treatment-Induced Adverse Events
1996
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine
1995
The Impact of Nontuberculous Myobacteria on Management of Presumed Pulmonary Tuberculosis
2001
Pancreatic cancer
2011 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer
2004
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Association Between Palliative Care and Patient and Caregiver Outcomes
2016 Standout
From radiotherapy to Targeted therapy: 20 years in the management of non-small-cell lung cancer.
2006
Receptors for Purines and Pyrimidines
1998 Standout
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
1997
Risk factors for acquired multidrug-resistant tuberculosis
2003
Serodiagnosis of Tuberculosis: Comparison of Immunoglobulin A (IgA) Response to Sulfolipid I with IgG and IgM Responses to 2,3-Diacyltrehalose, 2,3,6-Triacyltrehalose, and Cord Factor Antigens
2002
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
1993
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.
2006
The role of radiotherapy in cancer treatment
2005 Standout
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
The Immune Response in Tuberculosis
2013 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Evaluating patient-based outcome measures for use in clinical trials.
1998
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Infections due to non-tuberculous mycobacteria (NTM).
2004
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Hemodynamic Effects of Nonionic Contrast Bolus Injection and Oxygen Inhalation During Pulmonary Angiography in Patients With Chronic Major-Vessel Thromboembolic Pulmonary Hypertension
1996
The rv1184c Locus Encodes Chp2, an Acyltransferase in Mycobacterium tuberculosis Polyacyltrehalose Lipid Biosynthesis
2014 StandoutNobel
Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801
2009
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow
1992
A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer
2006
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Flow-mediated endothelial mechanotransduction
1995 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.
1994
Works of R.M. Rudd being referenced
Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients
1987
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial
1991
Humoral response to defined epitopes of tubercle bacilli in adult pulmonary and child tuberculosis
1988
Clinical evaluation of a serological assay using a monoclonal antibody (TB72) to the 38 kDa antigen of Mycobacterium tuberculosis
1994
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
2004
Assessment of ’quality of life’ using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer
1995
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
1994
Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group
2004
Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis.
1992
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
2005
Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC)
2002
Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen.
1989
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
1996
Use of the flexible film isolator as a single circuit hypoxic chamber for small animals
1985
The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting
2002
10 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 1. Results of a randomised trial in patients with localised, inoperable disease
1997
A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections
1985
Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992.
1994